Daniel Sherbenou, University of Colorado Cancer Center (IMAGE)

University of Colorado Anschutz

Daniel Sherbenou, University of Colorado Cancer Center

Caption

Daniel Sherbenou and colleagues develop tool to predict most useful multiple myeloma drugs.

Credit

University of Colorado Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.